FDAFDA · Food and drugs·Recall number D-1314-2020
Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx only, Manufactured for: Prasco Laboratories Mason, OH 45040 USA, Manufactured by: Aurolife Pharma LLC Dayton, NJ 08810, NDC 66993-680-30
Published June 24, 2020 · Recall initiated: May 26, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/ Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot #: 561180046A1, Exp 8/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.